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Abstract: Ventilatory function and inflammatory cells in airways were compared
between patients with type II (bronchiolar obstruction) asthma and those with
obstructive bronchiolitis. 1. Age and age at onset were higher in patients with type
II asthma than in those with obstructive bronchiolitis. IgE-mediated allergic reaction
was observed in patients with type II asthma, but not in those with obstructive
bronchiolitis. 2. In ventilatory function tests, all ventilatory parameters examined
were lower in patients with type II asthma compared to those with obstructive
bronchiolitis, and the differences were significant in FEV1.0% (p<o.oon, %MMF
(p<O.02), and V50 (p<O.01). 3. The proportion of SAL neutrophils was very high in
type II asthma (55.7%) and obstructive bronchiolitis (74.4%), however, this was not
significant. 4. Absolute numbers/SAL fluid of total cells, SAL macrophages and
SAL neutrophils were significantly higher in patients with obstructive bronchiolitis
than in those with type II asthma. 5. The results on absolute number/ mQ of SAL
cells demonstrated that number of SAL neutrophils markedly larger in patients with
obstructive bronchiolitis compared to those with type II asthma.
These results show that high proportion of SAL neutrophils was observed in the two
respiratory diseases, however, the degree of inflammation in airways was markedly
greater in obstructive bronchiol itis.
Key words: Type II asthma, Obstructive bronchiolitis, Ventilatory function, BAL
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Introduction
Inhalation of a relevant allergen induces
immediate bronchoconstriction, and late
asthmatic reaction l - 3 ), and then airway
hyperresponsiveness" 5). Allergen-induced air-
way hyperresponsiveness is associated with
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Results
Table 1. Cgaracteristics of patients with
type II asthma and those with
obstructive bronchiolitis
Type II 7 58.9 45,1 389 2/7asthma (105-1820)
Obstructive 9 48.8 41.7 115 0/9bronchiolitis (45-309)
HOm, house dust mite
RAST to
HOm
Serum IgE
(IU/ml)
No of
patientsDisease
Table 1 shows characteristics of patients
with type II asthma and those with obstruc-
tive bronchiolitis. Age and age at onset of
the disease were higher in patients with type
II asthma than in those with obstructive
bronchiolitis. The mean level of serum IgE
was higher in type II asthma patients com-
pared to those with obstructive bronchiolitis.
centrifugation of BAL fluid was resuspended
in Tris ACM. BAL cytology was performed
by observing 500 cells, excluding epithelial
cells, on smear preparations which were made
from BAL cell suspensions and stained with
May-Giemsa, The results were expressed as
percentages of the total cells, and absolute
number (X1Q6/BAL fluid andXI0 4/mP).
Ventilatory function tests, using a Box
Spiror 81S (Chest Co), were performed in all
subjects when they were free of attack.
The level of serum IgE was measured by
the radioimmunosorbent test (RIST) and IgE
antibodies to inhalant allergens were evalu-
ated by the redioallergosorbent test (RAST).
Statistically significant differences of the
mean were estimated using the unpaired
Student' t test. A p value of<0.05 was
regarded as significant.
Subjects and Methods
The subjects of this study were 7 patients
(1 female and 6 males) with type II (bron-
chiolar obstruction) asthma, and 9 patients
(4 females and 5 males) with obstructive
bronchiolitis. Type II asthma was assessed
according to a asthma classification method
by clinical symptoms (clinical diagnosis)I6-1B).
The subjects were reevaluated by a score
calculated from clinical findings and exami-
nations (score diagnosis)19). Obstructive bron-
chiolitis was diagnosed by chest X ray find-
ing, clinical findings and examinations.
BAL was performed according to a previ-
ously described method16- 2Il) when the subjects
were attack-free. Informed consent for this
BAL procedure was obtained from all study
subjects. The cell pellet obtained by
migration of inflammatory cells, lymphocy-
tes 6- B), neutrophils 9, 10), eosinophilsll-13), and
basophils I4). Thus, airway inflammation is a
common feature of bronchial asthma15).
Among three clinical types of asthma (type
lao simple bronchoconstriction, type lb.
Bronchoconstriction+hypersecretion, and type
II, bronchiolar obstruction), type II asthma
IS characterized by increased number of
neutrophils in bronchoalveolar lavage (BAL)
fluid and marked decrease In values of
FEV1.0 and V2516- 1B). In contrast, obstructive
bronchiolitis, which IS increasing in recent
years as the number of aged-patients in-
creases, IS also characterized by BAL
neutrophilia and obstructive ventilatory dys-
function in small airways.
In the present study, difference in inflam-
mation of small airways between type II
asthma and obstructive bronchiolitis was
examined by analyzing ventilatory function,
and the proportion and number of BAL cells.
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Difference in BAL cells between
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20
10
o
Fig. 2 .
100
90
80
en 70
Q) 60
u
..J 50
<l:
a:l 40
~ 30
RAST to house dust mite (HDm) was posi-
tive in 2 of 7 patients with type II
asthma, however, no patients with obstruc-
tive bronchiolitis showed a positive RAST to
HDm and other inhalant allergens.
In ventilatory function tests, 6 ventilatory
parameters were applied to evaluate differ-
ence between the two respiratory diseases.
The values of all ventilatory parameters were
lower in patients with type II asthma than
in those with obstructive bronchiolitis. The
differences were significant III FEV1.0%
.
(p<O.OOl), %MMF (p<0.02) and %V50
(p<O.Ol), as shown in Fig. 1.
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Fig. 1. Difference in ventilatory function
between patients with type II asthm-
a ( • ) and those with obstructive
bronchiolitis ( C!9 ). a,p<0.001, b,
p<0.02, c,p<O.Ol.
The proportion of BAL cells was compared
in the two diseases. The proportion of BAL
macrophages (Mac) was higher in patients
with type II asthma, however, this was not
significant. The proportion of BAL
neutrophils (Neut) was very high in both
respiratory diseases, and the proportion was
higher III patients with obstructive
bronchiolitis (74.4%) compared to those with
type II asthma (55.7%). However, this was
not significant. The proportions of BAL
lymphocytes (Lymph) and eosinophils (Eos)
were not different between the two diseases
(Fig. 2).
Comparison of absolute number/BAL fluid
obtained of BAL cells is demonstrated in
Table 2. The recovery rate of BAL fluid was
significantly larger in patients with obstruc-
tive bronchiolitis than in those with type II
asthma. The absolute numbers/BAL fluid of
total cells (p<O.OO, BAL macrophages
(p<0.02), and BAL neutrophils (p<0.05)
were significantly higher in patients with
obstructive bronchiolitis than in those with
type II asthma. Figure 3 reveals absolute
numbers/mP of BAL cells. The number of
BAL neutrophils was markedly larger (88.3
X 10 4 / me) in patients with obstructive
bronchiolitis compared to the number (l0.8
X10 4 /mP) in those with type II asthma.
Discussion
Clinical symptoms of patients with type
II (bronchiolar obstruction) asthma are
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Table 2. Absolute number of BAL cells in
patients with type II asthma and
obstructive bronchiolitis
Recovery No of cells 8AL cells (x 106 )
Disease rate (%) (x 106 ) Mac Lymph Neut Eos
Type II 18.6 a 4.8 b 177 c 29 249 d 20
asthma ±8.9 ±3.1 ±105 ±35 ±218 ±26
Obstructive 39.2 a 50.2 b 775 c 420 3787 d 26
bronchiolitis ±19.3 ±40.1 ±537 ±630 ±3123 ±40
a,p<0.05, b,p<O.Ol, c,p<0.02, d.p<0.05.
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Fig. 3. Absolute number (X10 4 /m£) of BAL
cells in patients with type II asthma
( • ) and obstructive bronchiolitis
( ~ ). a,p<O.02.
resemble to that of those with obstructive
bronchiolitis. The pathophysiological changes
in airways in the two kinds of respiratory
diseases are inflammation in small airways,
resulting in ventilatory dysfunction in these
airways. It is well known that airway in-
flammation is a major pathogenesis of bron-
chial asthma'5). Among inflammatory cells,
activated T lymphocytes and eosinophils play
an important role in triggering events of
asthma attacks 7 . 2Il • However, a role of
neutrophils in onset mechanisms of asthma
attacks has been also noted m recent
years22 Zl),
Our previous studies have shown that type
II, bronchiolar obstruction, asthma IS
charcterized by an increase in number of BAL
neutrophils and marked decrease in the value
of ventilatory parameters such as FEV1.0
.
and %V25 16- 18). BAL neutrophilia in type II
asthma might be associated with suppressed
humoral and cellular immunity2U5), which is
mainly caused by long-term glucocorticoid
therapy.
In this study, the two respiratory diseases,
which have resemble pathophysiological
changes in airways were compared in relation
to ventilatory function and proportions and
numbers of BAL cells. In ventilatory function
tests, the values of all parameters measured
were lower in patients with type II asthma
than in those with obstructive bronchiolitis,
and the differences were significant m
%FEV1.0, %MMF, and %V50, which repre-
sent airway narrowing. The results suggest
that airway narrowing is stronger in patients
with type II asthma compared to those with
obstructive bronchiolitis.
Regarding airway inflammation, a high
proportion of BAL neutrophils was observed
in both respiratory diseases, however, the
difference between the two diseases was not
significant. Absolute numbers per BAL fluid
and per m.e of BAL neutrophils were markedly
and significantly larger in patients with
obstructive bronchiolitis than in those with
type II asthma. Furthermore, the num-
bers/BAL fluid of total cells and macro-
phages were also significantly higher in pa-
tients with obstructive bronchiolitis. These
results demonstrate that airway inflamma-
tion is markedly stronger in patients with
obstructive bronchiolitis compared to that in
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those with type IT asthma.
References
1. Crimi E, Gianiorio P, Orengo G, Vol-
tolini S, Crimi P and Brusasco V : Late
asthmatic reaction to perennial and
seasomal allergens. J Allergy Clin Immunol
85 : 885-890, 1990.
2. Durham SR : The significance of late
responses in asthma. CEn Exp Allergy 21 :
3 - 7, 1991.
3. Inman MD, Watson R, Cockcrott DW,
Wong BJO, Hargreave FE and O'Byrne P
M : Reproducibility of allergen-induced
early and late asthmatic responses. J Al-
lergy Clin Immunol 95 : 1191-1195, 1995.
4. Cartier A, thomson NC, Frith PA,
Roberts Rand Hargreave FE : Allergen-
induced increase in bronchial responsiveness
to histamine : relationship to the late
asthmatic response and change in airway
caliber. J Allergy Clin Immunol 70 : 170-
177, 1982.
5. Gibbons WJ, Sharma A, Lougheed D and
Macklem PT: Detection of exceSSIve
bronchoconstriction in asthma. Am J
Respir Crit Care Med 153 : 582-589, 1996.
6. Kelly CA, Stenton SC, Ward C, Bird G,
Hendrick DJ and Walteres EH : Lymphocyt
e subsets in bronchoalveolar lavage fluid
obtained from stable asthmatics, and their
correlations with bronchial responsiveness.
CEn Exp Allergy 19: 169-175, 1989.
7. Walker C, Kaegi MK, Braun P and Blaser
K : Activated T cells and eosinophilia in
bronchoalveolar lavages from subjects with
asthma correlated with disease severity. J
Allergy Clin Immunol 88 : 935-952, 1991.
8. Wilson JW, Djukanovic R, Howarth PH
and Holgate ST : Lymphocyte activation in
bronchoalveolar lavage and peripheral blood
III atopic asthma. Am Rev Respir Dis 145 :
958-960, 1992.
9. Miadonna A, Milazzo N, Lorini M, Sala
A and Tedeschi A : Nasal neutrophilia and
release of myeloperoxidase induced by nasal
challenge with platelet activating factor:
Different degrees of responsiveness III
atopic and nonatopic subjects. J Allergy
Clin Immunol 97 : 957 -954, 1996.
10. Erjefalt JS, Sundler F and Person CGA :
Eosinophils, neutrophils, and venular gaps
in the airway mucosa at epithelial removal-
restitution. Am J Respir Crit Care Med 153
: 1666-1674, 1996.
11. deMonchy JG, Kauffman H, Venge P,
Koefer GH, Jansen HM, Sluiter HJ and
deVries K: Bronchoalveolar eosinophilia
during allergen-induced late asthmatic
reaction. Am Rev Respir Dis 131 : 373-
376, 1985.
12. Waedlaw AJ, Dunnette S, Gleich GJ,
Colilins JV and Kay AB : Eosinophils and
mast cells in bronchoalveolar lavage in
patients with mild asthma. Relationship to
bronchial hyperresponsiveness. Am Rev
Respir Dis 137 : 62-69, 1988.
13. ltoh K, Takahashi E, Mukaiyama 0,
Satoh Y and Yamaguchi T : Relationship
between airway eosinophilia and airway
hyperresponsiveness in a late asthmatic
model of guinea pigs. Int Arch Allergy
Immunol 109 : 86-94, 1996.
14. Tomioka M, Ida S, Shindoh Y, Ishihara T
and Takishima T: Mast cells III
bronchoalveolar lavage of patients with
bronchial asthma. Am Rev Respir Dis 129 :
1000 -1005, 1984.
15. Holgate ST, Djukanovic R, Wilson J,
Roche Wand Howarth PH : Inflammatory
process and bronchial hyperresponsiveness.
Clin Exp Allergy 21 : 30-36, 1991.
Type II asthma and obstructive bronchiolitis 19
16. Tanizaki Y, Kitani H, Okazaki M,
Mifune T, Mitsunobu F, Ochi K and
Harada H : Cellular composition of fluid in
the airways of patients with house dust
sensitive asthma, classified by clinical
symptoms. Intern Med 31 : 333-338, 1992.
17. Tanizaki Y, Kitani H, Okazaki M,
Mifune T, Mitsunobu F, Honke Nand
Kimura I : Characteristics of airway re-
sponses in patients with bronchial asthma.
Evaluation of asthma classification based
on clinical symptoms and findinhs. Jpn J
Allergol 42: 123-130, 1993.
18. Tanizaki Y, Kitani H, Okazaki M,
Mifune T, Mitsunobu F, Okano T, Honke N
and Kimura I : A new modified classifica-
tion of bronchial asthma based on clinical
symptoms. Intern Med 32: 197-203, 1993.
19. Tanizaki Y, Kitani H, Okazaki M,
Mifune T, Mitsunobu F, Koto N, Tada S,
Takahashi K and Kimura I : Asthma classi-
fication by score calculated from clinical
findings and examinations. Jpn J Allergol
41 : 489-495, 1992.
20. Tanizaki Y, Kitani H, Okazaki M,
Mifune T, Mitsunobu F and Kimura I : Ch
anges in the proportion of bronchoalveolar
lymphocytes, neutrophils and basophilic
cells and the release of histamine and
leukotrienes from bronchoalveolar cells in
patients with steroid-dependent intractable
asthma. Int Arch Allergy Immunol 101 :
196-202, 1993.
21. Durham SR, Ying S, Varney VA,
Jacobson MR, Suddederick RM, Mackey IS,
Kay AB and Hamid QA: Grass pollen
immunotherapy inhibits allergen-induced
infiltration of CD4+ T lymphocytes and
eosinophils in the nasal mucosa and in-
creases the number of cells expressing
messenger RNA for interferon- r. J Allergy
Clin Immunol 97 : 1356-1365, 1996.
22. Hughes JM, Mckay KO, Johnson PR,
Tragoulias S, Black JL and Armour CL :
Neutrophil-induced human bronchial hyper-
responsiveness In vito-pharmacological
modulation. CEn Exp Allergy 23 : 251-256,
1993.
23. Anticevich SZ, Hughes JM, Black JL and
Armour CL: Induction of hyperrespon-
siveness III human airway tissue by
neutrophils-mechanism of action. Clin Exp
Allergy 26 : 549-556, 1996.
24. Tanizaki Y, Kitani H, Okazaki M,
Mifune T, Mitsunobu F and Kimura I : Ef
fects of long-term glucocorticoid therapy
on bronchoalveolar cells in adult patients
with bronchial asthma. J Asthma 30 : 309-
318, 1993.
25. Tanizaki Y, Kitani H, Mifune T,
Mitsunobu F, Kajimoto K and Sugimoto
K : Effects of glucocorticoids on humoral
and cellular immunity and on airway in-
flammation III patients with steroid-
dependent intractable asthma. J Asthma 30
: 485-492, 1993.
20 TypeⅡasthmaandobstructivebronchiolitis
Ⅱ型 (細気管支閉塞)嘱息と閉塞性細気管支炎に
おける細気管支領域の炎症反応の差
御船尚志,光延文裕,保崎泰弘,芦田耕三,
横田 聡.柘野浩史,竹内一昭,名和由一郎,
谷崎勝朗,多田慎也1),原田実根 l)
岡山大学医学部附属病院三朝分院内科, 1)医学部
第2内科
Ⅱ型曝息と閉塞性細気管支炎の臨床的特徴につ
いて,換気機能および気道炎症反応を中心に検討
を加えた｡1.年齢,および発症年齢とも閉塞性
細気管支炎に比べⅡ型噛息において高い傾向が見
られた｡IgE系反応はⅡ型噛息では観察されたが,
閉塞性細気管支炎では見られなかった｡2.換気
機能では,測定された全ての換気パラメーターに
おいて,その値は閉塞性細気管支炎に比べⅡ型鴨
息でより低い値を示し,FEV1.0%,%MMFおよ●
び%V50では有意の差が見られた｡3.BAL液中
好中球頻度は,Ⅱ型喋息 (55.7%),閉塞性細気管
支炎 (74.4%)いずれにおいても高い値を示 した
が,両者間に有意の差は見られなかった｡4.-
方,BAL液中の絶対数では,Ⅱ型喋息に比べ,閉
塞性細気管支炎において,総細胞数,マクロファー
ジおよび好中球数が有意の高値を示した｡5.ま
た,lmPあたりの細胞数の比較でも,閉塞性細気
管支炎で好中球数が著明な高値を示した｡
これらの結果より,この2疾患では気道内好中
球増多は同様に見られるものの,その気道炎症の
程度は明らかに閉塞性細気管支炎でより高度であ
ることが示された｡
索引用語 :Ⅱ型噂息,閉塞性細気管支炎,換気機
舵,BAL好中球,IgE系反応
